Search filters

List of works by Debra M Sarasohn

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

scientific article published on 13 February 2017

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

scientific article published on 11 July 2014

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative

scientific article published on 06 June 2020

Causes of Avascular Hypoechoic Testicular Lesions Detected at Scrotal Ultrasound: Can They Be Considered Benign?

scientific article published in July 2017

Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual

scientific article

Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards

scientific article published on 01 March 2011

Is It Time to Centralize Ovarian Cancer Care in the United States?

scientific article published on 28 October 2015

Limitations of CT during PET/CT.

scientific article published on 14 September 2007

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease

scientific article published on 16 April 2019

Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance.

scientific article published on 2 March 2015

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr

scientific article

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma

scientific article

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma

scientific article published on 23 February 2011

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

scientific article published on 3 August 2009

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

scientific article published in November 2007

Prognostic nomogram for renal insufficiency after radical or partial nephrectomy

scientific article published on 01 August 2006

Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residu

scientific article

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.

scientific article published on 30 September 2016

Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy.

scientific article published on 20 June 2013

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

scientific article

Paulina is supported by:

About Paulina

Help